Inhibition of cytokinesis by a lipid metabolite, psychosine

被引:96
作者
Kanazawa, T [1 ]
Nakamura, S
Momoi, M
Yamaji, T
Takematsu, H
Yano, H
Sabe, H
Yamamoto, A
Kawasaki, T
Kozutsumi, Y
机构
[1] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan
[3] Osaka Biosci Inst, Dept Biol Mol, Suita, Osaka 5650874, Japan
[4] Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 5700074, Japan
[5] Kansai Med Univ, Liver Res Ctr, Moriguchi, Osaka 5700074, Japan
关键词
cytokinesis; multinuclear cell; globoid cell leukodystrophy; psychosine; actin filament;
D O I
10.1083/jcb.149.4.943
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although a number of cellular components of cytokinesis have been identified, little is known about the derailed mechanisms underlying this process. Here, we report that the lipid metabolite psychosine (galactosylsphingosine), derived from galactosylceramide, induced formation of multinuclear cells from a variety of nonadherent and adherent cells due to inhibition of cytokinesis, When psychosine was added to the human myelomonocyte cell line U937, which was the most sensitive among the cell lines tested, cleavage furrow formed either incompletely or almost completely. However, abnormal contractile movement was detected in which the cellular contents of one of the hemispheres of the contracting cell were transferred into its counterpart. Finally, the cleavage furrow disappeared and cytokinesis was reversed. Psychosine treatment also induced giant clots of actin filaments in the cells that probably consisted of small vacuoles with filamentous structures, suggesting that psychosine affected actin reorganization, These observations could account for the formation of multinuclear globoid cells in the brains of patients with globoid eel leukodystrophy, a neurological disorder characterized by the accumulation of psychosine due to galactosylceramidase deficiency.
引用
收藏
页码:943 / 950
页数:8
相关论文
共 38 条
[1]   Tissue culture model of Krabbe's disease: Psychosine cytotoxicity in rat oligodendrocyte culture [J].
Cho, KH ;
Kim, MW ;
Kim, SU .
DEVELOPMENTAL NEUROSCIENCE, 1997, 19 (04) :321-327
[2]   Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability [J].
Coetzee, T ;
Fujita, N ;
Dupree, J ;
Shi, R ;
Blight, A ;
Suzuki, K ;
Suzuki, K ;
Popko, B .
CELL, 1996, 86 (02) :209-219
[3]   KINETICS OF INHIBITION OF PURIFIED AND MITOCHONDRIAL CYTOCHROME-C-OXIDASE BY PSYCHOSINE (BETA-GALACTOSYLSPHINOGOSINE) [J].
COOPER, CE ;
MARKUS, M ;
SEETULSINGH, SP ;
WRIGGLESWORTH, JM .
BIOCHEMICAL JOURNAL, 1993, 290 :139-144
[4]   Endocytosis of GPI-anchored proteins in human lymphocytes: Role of glycolipid-based domains, actin cytoskeleton, and protein kinases [J].
Deckert, M ;
Ticchioni, M ;
Bernard, A .
JOURNAL OF CELL BIOLOGY, 1996, 133 (04) :791-799
[5]   HEREDITARY LEUCODYSTROPHY IN THE MOUSE - THE NEW MUTANT TWITCHER [J].
DUCHEN, LW ;
EICHER, EM ;
JACOBS, JM ;
SCARAVILLI, F ;
TEIXEIRA, F .
BRAIN, 1980, 103 (SEP) :695-710
[6]   NATURAL-KILLER CELLS KILL TUMOR-CELLS AT A GIVEN STAGE OF DIFFERENTIATION [J].
GIDLUND, M ;
ORN, A ;
PATTENGALE, PK ;
JANSSON, M ;
WIGZELL, H ;
NILSSON, K .
NATURE, 1981, 292 (5826) :848-850
[7]   The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways [J].
Gonda, K ;
Okamoto, H ;
Takuwa, N ;
Yatomi, Y ;
Okazaki, H ;
Sakurai, T ;
Kimura, S ;
Sillard, R ;
Harii, K ;
Takuwa, Y .
BIOCHEMICAL JOURNAL, 1999, 337 :67-75
[8]   Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis [J].
Goto, H ;
Kosako, H ;
Tanabe, K ;
Yanagida, M ;
Sakurai, M ;
Amano, M ;
Kaibuchi, K ;
Inagaki, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11728-11736
[9]   LYSOSPHINGOLIPIDS INHIBIT PROTEIN-KINASE-C - IMPLICATIONS FOR THE SPHINGOLIPIDOSES [J].
HANNUN, YA ;
BELL, RM .
SCIENCE, 1987, 235 (4789) :670-674
[10]  
Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO